vs
Side-by-side financial comparison of TriSalus Life Sciences, Inc. (TLSI) and TECHPRECISION CORP (TPCS). Click either name above to swap in a different company.
TriSalus Life Sciences, Inc. is the larger business by last-quarter revenue ($13.2M vs $7.1M, roughly 1.9× TECHPRECISION CORP). TECHPRECISION CORP runs the higher net margin — -20.8% vs -73.9%, a 53.1% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs -6.9%). TECHPRECISION CORP produced more free cash flow last quarter ($-827.0K vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs -9.2%).
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
TechPrecision Corp is a manufacturer of custom high-precision metal fabricated components and integrated systems, serving aerospace, defense, medical technology, renewable energy, and industrial end markets primarily across North America and Europe. It specializes in producing tight-tolerance, mission-critical parts that adhere to rigorous industry quality requirements.
TLSI vs TPCS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $13.2M | $7.1M |
| Net Profit | $-9.8M | $-1.5M |
| Gross Margin | 86.7% | 5.4% |
| Operating Margin | -24.8% | -19.1% |
| Net Margin | -73.9% | -20.8% |
| Revenue YoY | 59.8% | -6.9% |
| Net Profit YoY | 3.5% | -84.4% |
| EPS (diluted) | $-0.22 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.2M | $7.1M | ||
| Q3 25 | $11.6M | $9.1M | ||
| Q2 25 | $11.2M | $7.4M | ||
| Q1 25 | $9.2M | $9.5M | ||
| Q4 24 | $8.3M | $7.6M | ||
| Q3 24 | $7.3M | $8.9M | ||
| Q2 24 | $7.4M | $8.0M | ||
| Q1 24 | $6.5M | $8.6M |
| Q4 25 | $-9.8M | $-1.5M | ||
| Q3 25 | $-10.8M | $825.0K | ||
| Q2 25 | $-8.3M | $-597.0K | ||
| Q1 25 | $-10.4M | $112.0K | ||
| Q4 24 | $-10.1M | $-799.0K | ||
| Q3 24 | $-2.4M | $-601.0K | ||
| Q2 24 | $-4.3M | $-1.5M | ||
| Q1 24 | $-13.2M | $-5.1M |
| Q4 25 | 86.7% | 5.4% | ||
| Q3 25 | 83.5% | 27.1% | ||
| Q2 25 | 83.9% | 14.0% | ||
| Q1 25 | 83.7% | 22.0% | ||
| Q4 24 | 85.3% | 13.0% | ||
| Q3 24 | 86.3% | 11.3% | ||
| Q2 24 | 87.6% | 3.0% | ||
| Q1 24 | 85.0% | 14.3% |
| Q4 25 | -24.8% | -19.1% | ||
| Q3 25 | -77.9% | 10.4% | ||
| Q2 25 | -65.4% | -6.3% | ||
| Q1 25 | -79.9% | 3.9% | ||
| Q4 24 | -91.8% | -9.1% | ||
| Q3 24 | -118.9% | -5.5% | ||
| Q2 24 | -111.0% | -16.8% | ||
| Q1 24 | -180.8% | -28.6% |
| Q4 25 | -73.9% | -20.8% | ||
| Q3 25 | -93.5% | 9.1% | ||
| Q2 25 | -73.9% | -8.1% | ||
| Q1 25 | -113.2% | 1.2% | ||
| Q4 24 | -122.4% | -10.5% | ||
| Q3 24 | -32.6% | -6.7% | ||
| Q2 24 | -58.8% | -18.3% | ||
| Q1 24 | -204.5% | -59.5% |
| Q4 25 | $-0.22 | $-0.15 | ||
| Q3 25 | $-0.96 | $0.08 | ||
| Q2 25 | $-0.27 | $-0.06 | ||
| Q1 25 | $-0.39 | $0.01 | ||
| Q4 24 | $-0.38 | $-0.08 | ||
| Q3 24 | $-0.12 | $-0.06 | ||
| Q2 24 | $-0.21 | $-0.16 | ||
| Q1 24 | $-0.60 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $20.4M | $50.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-33.9M | $8.0M |
| Total Assets | $35.3M | $32.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.4M | $50.0K | ||
| Q3 25 | $22.7M | $220.0K | ||
| Q2 25 | $26.5M | $143.0K | ||
| Q1 25 | $13.0M | $195.0K | ||
| Q4 24 | $8.5M | $165.0K | ||
| Q3 24 | $11.3M | $132.0K | ||
| Q2 24 | $16.5M | $44.8K | ||
| Q1 24 | $4.0M | $138.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $3.0K | ||
| Q4 24 | — | $19.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-33.9M | $8.0M | ||
| Q3 25 | $-26.7M | $9.1M | ||
| Q2 25 | $-19.4M | $8.2M | ||
| Q1 25 | $-34.4M | $8.7M | ||
| Q4 24 | $-25.9M | $8.1M | ||
| Q3 24 | $-20.4M | $8.9M | ||
| Q2 24 | $-25.3M | $7.9M | ||
| Q1 24 | $-36.0M | $7.8M |
| Q4 25 | $35.3M | $32.8M | ||
| Q3 25 | $36.5M | $33.8M | ||
| Q2 25 | $41.3M | $32.1M | ||
| Q1 25 | $28.6M | $33.5M | ||
| Q4 24 | $24.0M | $32.2M | ||
| Q3 24 | $27.5M | $35.0M | ||
| Q2 24 | $32.4M | $35.7M | ||
| Q1 24 | $17.9M | $34.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $183.0K |
| Free Cash FlowOCF − Capex | $-2.5M | $-827.0K |
| FCF MarginFCF / Revenue | -19.1% | -11.7% |
| Capex IntensityCapex / Revenue | 0.3% | 14.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-19.1M | $-4.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $183.0K | ||
| Q3 25 | $-3.7M | $-1.1M | ||
| Q2 25 | $-7.3M | $646.0K | ||
| Q1 25 | $-4.5M | $396.0K | ||
| Q4 24 | $-5.7M | $-570.0K | ||
| Q3 24 | $-10.8M | $-532.0K | ||
| Q2 24 | $-13.4M | $107.0K | ||
| Q1 24 | $-10.9M | $-452.0K |
| Q4 25 | $-2.5M | $-827.0K | ||
| Q3 25 | $-3.9M | $-2.1M | ||
| Q2 25 | $-7.4M | $-604.0K | ||
| Q1 25 | $-5.3M | $-930.0K | ||
| Q4 24 | $-5.8M | $-1.7M | ||
| Q3 24 | $-11.0M | $-2.0M | ||
| Q2 24 | $-13.5M | $-94.0K | ||
| Q1 24 | $-10.9M | $-900.0K |
| Q4 25 | -19.1% | -11.7% | ||
| Q3 25 | -33.9% | -22.9% | ||
| Q2 25 | -66.1% | -8.2% | ||
| Q1 25 | -57.3% | -9.8% | ||
| Q4 24 | -69.7% | -22.9% | ||
| Q3 24 | -149.9% | -21.8% | ||
| Q2 24 | -183.1% | -1.2% | ||
| Q1 24 | -169.3% | -10.5% |
| Q4 25 | 0.3% | 14.2% | ||
| Q3 25 | 1.9% | 11.0% | ||
| Q2 25 | 0.8% | 16.9% | ||
| Q1 25 | 8.2% | 14.0% | ||
| Q4 24 | 0.6% | 15.4% | ||
| Q3 24 | 2.3% | 15.9% | ||
| Q2 24 | 0.8% | 2.5% | ||
| Q1 24 | 1.0% | 5.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.31× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.54× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TLSI
Segment breakdown not available.
TPCS
| Defense | $6.7M | 94% |
| Other | $410.0K | 6% |
